We are live on ! Find out more
Grantham, Mayo, Van Otterloo & Co (GMO)

Grantham, Mayo, Van Otterloo & Co (GMO) Portfolio holdings

AUM $39.1B
1-Year Est. Return 28.69%
This Fund
S&P 500
This Quarter Est. Return
+2.03%
1 Year Est. Return
+28.69%
3 Year Est. Return
+71.15%
5 Year Est. Return
+97.93%
10 Year Est. Return
+429.41%
AUM
$29.6B
AUM Growth
+$2.09B
Cap. Flow
+$1.9B
Cap. Flow %
6.41%
Top 10 Hldgs %
35.06%
Holding
589
New
76
Increased
233
Reduced
176
Closed
64

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$275M
2
TMO icon
Thermo Fisher Scientific
TMO
+$244M
3
JNJ icon
Johnson & Johnson
JNJ
+$178M
4
PR
Permian Resources
PR
+$176M
5
HLT icon
Hilton Worldwide
HLT
+$140M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$171M
2
AMZN icon
Amazon
AMZN
+$106M
3
TSM icon
TSMC
TSM
+$90.2M
4
PXD
Pioneer Natural Resource Co.
PXD
+$72.5M
5
GE icon
GE Aerospace
GE
+$65.4M

Sector Composition

Rank Sector Weight
1 Technology 29.91%
2 Healthcare 22.8%
3 Financials 10.47%
4 Communication Services 9.58%
5 Consumer Discretionary 7.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.83T
$1.69B 5.71%
3,782,328
+185,260
+5% +$78.2M
AAPL icon
2
Apple
AAPL
$4.72T
$1.27B 4.28%
6,013,397
+1,476,341
+33% +$275M
GOOGL icon
3
Alphabet (Google) Class A
GOOGL
$3.89T
$1.26B 4.27%
6,937,885
+124,392
+2% +$21M
META icon
4
Meta Platforms (Facebook)
META
$1.54T
$1.11B 3.76%
2,207,020
+157,255
+8% +$76.4M
UNH icon
5
UnitedHealth
UNH
$385B
$1.01B 3.41%
1,982,532
+171,215
+9% +$83.9M
JNJ icon
6
Johnson & Johnson
JNJ
$624B
$881M 2.97%
6,024,386
+1,196,854
+25% +$178M
LRCX icon
7
Lam Research
LRCX
$400B
$817M 2.76%
7,676,180
+268,000
+4% +$25.7M
ORCL icon
8
Oracle
ORCL
$346B
$804M 2.71%
5,692,642
+186,320
+3% +$23.1M
TXN icon
9
Texas Instruments
TXN
$260B
$786M 2.65%
4,039,455
+167,863
+4% +$31M
KO icon
10
Coca-Cola
KO
$349B
$749M 2.53%
11,772,050
+697,164
+6% +$43.2M
ELV icon
11
Elevance Health
ELV
$82.3B
$731M 2.47%
1,349,868
+102,603
+8% +$54.2M
AMZN icon
12
Amazon
AMZN
$2.51T
$677M 2.29%
3,501,043
-578,050
-14% -$106M
MRK icon
13
Merck
MRK
$322B
$660M 2.23%
5,328,292
+601,234
+13% +$77.4M
ISRG icon
14
Intuitive Surgical
ISRG
$119B
$634M 2.14%
1,424,317
+58,167
+4% +$23.2M
ACN icon
15
Accenture
ACN
$84.9B
$617M 2.08%
2,032,727
+155,196
+8% +$47.5M
ABT icon
16
Abbott
ABT
$175B
$602M 2.03%
5,792,160
+384,152
+7% +$40.7M
TJX icon
17
TJX Companies
TJX
$170B
$596M 2.01%
5,414,490
+222,464
+4% +$22.4M
KLAC icon
18
KLA
KLAC
$286B
$572M 1.93%
6,937,900
+323,190
+5% +$23.9M
WFC icon
19
Wells Fargo
WFC
$261B
$567M 1.91%
9,538,858
+598,312
+7% +$35.3M
CRM icon
20
Salesforce
CRM
$129B
$544M 1.84%
2,117,674
+133,503
+7% +$35.7M
USB icon
21
US Bancorp
USB
$98.7B
$480M 1.62%
12,090,580
+929,005
+8% +$37.9M
OTIS icon
22
Otis Worldwide
OTIS
$27.2B
$466M 1.57%
4,841,268
+204,190
+4% +$19.7M
V icon
23
Visa
V
$669B
$462M 1.56%
1,759,177
+108,271
+7% +$29.7M
LLY icon
24
Eli Lilly
LLY
$1.06T
$426M 1.44%
470,489
-213,297
-31% -$171M
STZ icon
25
Constellation Brands
STZ
$22.1B
$381M 1.29%
1,480,070
+193,991
+15% +$49.9M
1
2 3 4 5

Similar funds

Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Nomura Asset Management
Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
Empower Advisory Group
Empower Advisory Group Greenwood Village, Colorado $38.5B AUM 18.4% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $38.1B AUM

Grantham, Mayo, Van Otterloo & Co (GMO)'s Q2 2024 Portfolio in Review

As of Q2 2024, Grantham, Mayo, Van Otterloo & Co (GMO) held 589 positions worth $29.6B, up 7.6% from $27.5B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Grantham, Mayo, Van Otterloo & Co (GMO) deployed $1.9B of net new capital in Q2 2024, opening 76 new positions and adding to 233 existing holdings. Its largest new stake was Thermo Fisher Scientific: 425,639 shares worth $235M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Eli Lilly, an estimated $171M trimmed.

  • Grantham, Mayo, Van Otterloo & Co (GMO)'s largest Q2 2024 buy was Thermo Fisher Scientific: 425,639 shares worth $235M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) added most to Apple in Q2 2024, an estimated $275M increase.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s biggest Q2 2024 reduction was Eli Lilly, cutting an estimated $171M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $72.5M.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s ten largest holdings make up 35% of its $29.6B portfolio in Q2 2024.
  • Grantham, Mayo, Van Otterloo & Co (GMO) opened 76 new positions and closed 64 in Q2 2024.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio value rose 7.6% quarter-over-quarter to $29.6B.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2024, filed 13 Aug 2024.